Tables index

From

A Clinical Trial of Nitazoxanide and Albendazole in Biliary Ascariasis

Hasina Nasreen

American Journal of Medicine Studies. 2017, 5(1), 18-24 doi:10.12691/ajms-5-1-2
  • Table 1. Distribution of the study groups
  • Table 2. Distribution of age among study groups (with X2 test significance)
  • Table 3. Distribution of sex among study groups (with X2 test significance)
  • Table 4. Distribution of presenting symptoms among the study groups (with X2 test significance)
  • Table 5. Distribution of presenting signs among study groups (with X2 test significance)
  • Table 6. Distribution of distinct clinical presentations among study groups (with X2 test significance)
  • Table 7. Statistics of hematological investigations among study groups
  • Table 8. Statistics of biochemical investigations among study groups
  • Table 9. Distribution of pain relief among study groups (n = 130) (with X2 test significance)
  • Table 10. Distribution of first follow-up USG findings among study groups (n = 123) (with X2 test significance)
  • Table 11. Distribution of first follow-up USG comments among study groups (n = 41) (with X2 test significance)
  • Table 12. Distribution of second follow-up USG findings among study groups (n = 36) (with X2 test significance)
  • Table 13. Distribution of treatment outcome among study groups (n = 130) (with X2 test significance)